|
Q1 2023
Filed on May 15, 2023
|
17,676
|
$47.34 - $51.12
$837K - $904K
|
|
|
Q1 2023
Filed on May 15, 2023
|
771
|
$239.75 - $277.0
$185K - $214K
|
|
|
Q1 2023
Filed on May 15, 2023
|
9,443
|
$21.31 - $30.81
$201K - $291K
|
|
|
Q1 2023
Filed on May 15, 2023
|
4,942
|
$34.16 - $52.64
$169K - $260K
|
|
|
Q1 2023
Filed on May 15, 2023
|
20,455
|
$11.28 - $19.06
$231K - $390K
|
|
|
Q1 2023
Filed on May 15, 2023
|
6,749
|
$31.74 - $45.73
$214K - $309K
|
|
|
Q1 2023
Filed on May 15, 2023
|
10,669
|
$37.04 - $39.5
$395K - $421K
|
|
|
Q1 2023
Filed on May 15, 2023
|
6,106
|
$66.27 - $72.39
$405K - $442K
|
|
|
Q1 2023
Filed on May 15, 2023
|
8,662
|
$43.46 - $48.07
$376K - $416K
|
|
|
Q1 2023
Filed on May 15, 2023
|
10,093
|
$36.11 - $44.73
$364K - $451K
|
|
|
Q1 2023
Filed on May 15, 2023
|
6,359
|
$51.83 - $79.63
$330K - $506K
|
|
|
Q1 2023
Filed on May 15, 2023
|
12,604
|
$34.88 - $43.22
$440K - $545K
|
|
Supernus Pharma 0.625 04/01/23 Cvt Ma Td
|
Q1 2023
Filed on May 15, 2023
|
10,000
|
N/A
|
|